Second Japan High Court ruling on Iressa favours AstraZeneca
This article was originally published in Scrip
Executive Summary
The Osaka High Court in Japan has issued a ruling in favour of AstraZeneca in a long-running case relating to side-effects and deaths during the use of the lung cancer drug Iressa (gefitinib).